0: As life expectancy is rising and chronical pathologies along with it, the prevalence of accompanying pain is expected to increase yearly, with higher prevalence in elderly patients, where the treatment is also more sensitive [ 6,  7].
1: Considering the above, new therapeutic agents with increased efficacy, less side effects, and lower costs and leading to an improved quality of life [ 8 11] should become one of the primary objectives in modern medical research, together with constant monitoring [ 12] of the previous mentioned aspects.
